Sylogist Ltd. (TSE:SYZ - Free Report) - Equities researchers at Stifel Canada dropped their Q2 2025 earnings per share (EPS) estimates for shares of Sylogist in a research report issued to clients and investors on Thursday, May 15th. Stifel Canada analyst S. Sukumar now expects that the company will earn $0.00 per share for the quarter, down from their prior forecast of $0.05. The consensus estimate for Sylogist's current full-year earnings is $0.24 per share. Stifel Canada also issued estimates for Sylogist's Q3 2025 earnings at $0.04 EPS and Q4 2025 earnings at $0.08 EPS.
Sylogist Trading Down 3.4%
SYZ traded down C$0.32 during midday trading on Monday, reaching C$8.97. 5,727 shares of the company's stock traded hands, compared to its average volume of 48,117. The firm has a fifty day moving average of C$8.51 and a two-hundred day moving average of C$9.27. The stock has a market capitalization of C$212.10 million, a price-to-earnings ratio of 199.06 and a beta of 0.82. The company has a debt-to-equity ratio of 47.19, a current ratio of 0.54 and a quick ratio of 0.51. Sylogist has a 52 week low of C$6.33 and a 52 week high of C$11.60.
Sylogist Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 12th. Investors of record on Wednesday, March 12th were issued a dividend of $0.01 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.45%. Sylogist's dividend payout ratio is presently 88.77%.
About Sylogist
(
Get Free Report)
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.
Recommended Stories
Before you consider Sylogist, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.
While Sylogist currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
